Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
472
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
Pridiktiv has been acquired by Corilus
Healthcare | TMT | Private Equity

Pridiktiv has been acquired by Corilus

The shareholders and founders of Pridiktiv NV have sold the company to Corilus.

Learn more
Sterima has been acquired by Pollet Medical Group
Healthcare | Other Industries

Sterima has been acquired by Pollet Medical Group

The shareholders of Sterima have sold the company to Pollet Medical Group. Financial details have not been disclosed.

Learn more
“Oaklins guided me and my team throughout the entire process and advised us on the various aspects of the complex transaction structure. Their financial expertise, market understanding and process management were instrumental in providing us comfort and support, but moreover helped us to keep on top of things and focus on what matters.”

Jeroen De Backer

CEO, Pridiktiv NV

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=BE&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Belgian radioisotope producer secures US$104.1 million to expand global production

DEAL FLASH: PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Oaklins’ team in Belgium acted as the sole financial advisor in this transaction.

Learn more

Talk to our local advisors

Ghislain de Lathuy

Director
Brussels, Belgium
Oaklins KBC Securities

Meet our global industry specialists

Antoine Lemaire

Partner
Paris, France
Oaklins France

Robert Boersma

Partner
Amsterdam, Netherlands
Oaklins Netherlands

Stuart Goodman

Partner
London, United Kingdom
Oaklins Evelyn Partners

Michael Jewell

Partner
London, United Kingdom
Oaklins Cavendish

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital